| ¿µ¹® | osmotic fragility | ÇÑ±Û | »ïÅõ¾ÐÃë¾à¼º |
|---|---|---|---|
| ¼³¸í | ÀûÇ÷±¸¼¼Æ÷ÀÇ »ïÅõ¾Ð Ư¼º º¯È¿¡ ´ëÇÑ ¹Î°¨¼º. ÀûÇ÷±¸°¡ Àú³óµµÀÇ ³ªÆ®·ý ¿ë¾×¿¡ ³ëÃâÇÏ¸é ¼¼Æ÷¸·ÀÇ ´É·ÂÀ» ÃʰúÇÒ ¶§±îÁö ´Ù·®ÀÇ ¹°À» Èí¼öÇÏ¿© ºÎÇ®¾î¿Ã¶ó ÆÄ¿ÇÏ°í °í³óµµÀÇ ³ªÆ®·ý ¿ë¾×¿¡ ³ëÃâÇϸé ÀûÇ÷±¸ÀÇ ¼¼Æ÷³»¾×ÀÌ ºüÁ®³ª°¡ Å©±â°¡ ÁÙ¾îµé¸ç ÆÄ±«µÈ´Ù. ¿¹¿ÜÀû Ãë¾à¼ºÀ̳ª ÀúÇ×¼ºÀº ƯÁ¤ º´ÀÇ Áø´ÜÀû ±âÁØÀÌ µÉ¼ö ÀÖ´Ù. Á¤»ó¼¼Æ÷´Â 0.39~0.45% ¼Ò±Ý¹° ¿ë¾×¿¡¼ ¿ëÇ÷ÀÌ ½ÃÀ۵Ǹç, 37¡É(98.6¢µ)¿¡¼ 0.30~0.33% ¼Ò±Ý ¿ë¾×¿¡ ÀûÇ÷±¸¸¦ ³ëÃâ½ÃŰ¸é ¿ëÇ÷Àº 24½Ã°£ À̳»¿¡ ¿Ï·áµÈ´Ù. |
||
| ¿µ¹® | bone marrow | ÇÑ±Û | °ñ¼ö |
|---|---|---|---|
| ¼³¸í | Ç÷±¸¼¼Æ÷¸¦ »ý¼ºÇÏ´Â Àå¼Ò¸¦ À̸£´Â ¸». ¾î¸°ÀÌ¿¡ À־ ¸ðµç »À¿¡ °ñ¼ö°¡ Á¸ÀçÇÏÁö¸¸ ¾î¸¥ÀÌ µÇ¸é ´ë°³ ±ä»ÀÀÇ ³»ºÎ³ª ³³ÀÛ»ÀÀÇ ³»ºÎ¿¡¸¸ Á¸ÀçÇÑ´Ù. Ç÷±¸¸¦ ¿Õ¼ºÇÏ°Ô »ý¼ºÀ» ÇÏ´Â °ñ¼ö´Â Àû»öÀ» ¶ì°Ô µÇ¹Ç·Î À̰ÍÀ» Àû»ö°ñ¼ö¶ó°í ÇÑ´Ù. Ç÷¾×À» »ý¼ºÇÏÁö ¾Ê´Â °ñ¼öÀÇ °æ¿ì´Â ±×°÷¿¡ Áö¹æÁúÀÇ Ä§ÂøÀÌ ÀÖ¾î¼ È²»öÀ¸·Î º¯»öµÇ¹Ç·Î À̰÷À» Ȳ»ö°ñ¼ö¶ó°í ÇÑ´Ù. ¾î¸¥¿¡ À־ ¸î¸îÀÇ »À¸¦ Á¦¿ÜÇÏ°í °ÅÀÇ ÀüºÎ°¡ Àû»ö°ñ¼ö°¡ Ȳ»ö°ñ¼ö·Î ´ëÄ¡µÇ¾î ÀÖ´Ù. |
||
| ¿µ¹® | bone marrow biopsy | ÇÑ±Û | °ñ¼ö»ý°Ë |
|---|---|---|---|
| ¼³¸í | °ñ¼ö¸¦ Áø´ÜÀ̳ª º´¿¡ ÀÇÇÑ º¯È¸¦ ¾Ë±âÀ§Çؼ äÃëÇÏ´Â °Í. |
||
| ¿µ¹® | bone marrow transplantation | ÇÑ±Û | °ñ¼öÀÌ½Ä |
|---|---|---|---|
| ¼³¸í | ȯÀÚÀÇ º´µç °ñ¼ö ´ë½Å °Ç°ÇÑ °ñ¼ö¼¼Æ÷¸¦ À̽ÄÇϴ óġ-¾ÏÄ¡·á¿¡ ¹æ»ç¼±¿ä¹ýÀ̳ª ÈÇпä¹ýÀ» ½èÀ» °æ¿ì ±× ºÎÀÛ¿ëÀ¸·Î °ñ¼öÀÇ ±â´ÉÀÌ ±Øµµ·Î ³ªºüÁ³À» ¶§³ª ¶Ç´Â ¹éÇ÷º´ÀÇ °æ¿ì¿¡ ¸é¿ª¿ä¹ýÀ¸·Î ÀÌ¿ëµÈ´Ù. ¹æ¹ýÀº °Ç°ÇÑ °ñ¼ö¾×À» äÃëÇÏ¿© Àλê¿ÏÃæ¾×À» ¼¯Àº ¸µ°Å¾×¿¡ ºÎÀ¯½ÃÄÑ ¿©°úÇÑ ´ÙÀ½ Á¤¸Æ¿¡ ÁÖ»çÇÑ´Ù. ÁÖÀÔÇÑ °ñ¼ö°¡ ü³»¿¡ Âø»óÇÏ¿© ¹ø½ÄÇϱ⠽±°Ô ÇÒ ¸ñÀûÀ¸·Î ¹Ì¸® X¼±À» Á¶»çÇÏ¿© À̽Ĺ޴ ȯÀÚÀÇ Ç×ü±â´ÉÀ» ¾ïÁ¦ÇØ µÑ Çʿ䰡 ÀÖ´Ù. ÀÌ Á¶ÀÛÀº ±Þ¼º ¹æ»ç´ÉÁõÀ» ÀÏÀ¸Å°±â ¶§¹®¿¡ ¿©·¯ °¡Áö º¸È£Ä¡·á°¡ ÇÊ¿äÇÏ´Ù. ±×·¯³ª °ñ¼ö¸¦ À̽ÄÇÏ¸é ±Þ¼º ¹æ»ç´ÉÁõÀ» °¡º±°Ô ³Ñ±æ ¼ö ÀÖ´Ù°í ÇÏ¿© ¹Ý´ë·Î ¹æ»ç´ÉÀ» ´ë·®À¸·Î Á¶»ç¹ÞÀº »ç¶÷¿¡°Ô ±× Ä¡·á¹ýÀ¸·Î ÀÌ¿ëµÇ±âµµ ÇÑ´Ù. À̽Ŀ¡´Â ½º½º·ÎÀÇ °ñ¼ö¼¼Æ÷¸¦ ¹Ì¸® äÃëÇØ ³õ°í ÈÄ¿¡ Àڽſ¡°Ô ÁÖÀÔÇÏ´Â ÀÚ°¡À̽İú À϶õ¼º½ÖµÕÀÌÀÇ ÇÑÂÊ¿¡¼ °ñ¼ö¼¼Æ÷¸¦ ÁÖÀÔÇÏ´Â µ¿°èÀÌ½Ä ¹× Á¶Á÷ÀûÇÕÇ׿øÀÌ ÀÏÄ¡ÇÑ Å¸ÀÎÀÇ °ñ¼ö¼¼Æ÷¸¦ ÁÖÀÔÇÏ´Â µ¿Á¾À̽ÄÀÌ ÀÖ´Ù. ´ë»óº´À¸·Î ¹éÇ÷º´, Àç»ýºÒ·®ºóÇ÷, ¼±Ãµ¸é¿ª°áÇÌÁõ µîÀÌ ÀÖ´Ù. ÀϹÝÀûÀ¸·Î °·ÂÇÑ ¸é¿ª¾ïÁ¦Á¦ÀÇ Åõ¿©°¡ ÇÊ¿äÇÏ´Ù. ºÎÀÛ¿ëÀ¸·Î¼´Â °ñ¼öÀÌ½Ä ÈÄ ÀÌ½ÄÆí´ë¼÷ÁÖº´, ±âȸ°¨¿° µîÀÌ ÀÖ´Ù. |
||
| ¿µ¹® | zygomatic bone | ÇÑ±Û | ±¤´ë»À |
|---|---|---|---|
| ¼³¸í | ¾ó±¼º¼ºÎºÐÀÇ µ¹ÃâÀ» ¸¸µå´Â »ÀÀÌ¸ç ´«È®ÀÇ ¾Æ·¡ ¹Ù±ùÂÊ¿¡ À§Ä¡ÇÑ´Ù. ´ë·« ¸¶¸§¸ð²ÃÀ̸ç À§ÅλÀ, À̸¶»À ¹× °üÀÚ»ÀÀÇ ±¤´ë»Àµ¹±â¿¡ ³¢¾î ÀÖ´Ù. °üÀÚµ¹±â´Â µÚÂÊÀ¸·Î µ¹ÃâÇÏ¿© °üÀÚ»ÀÀÇ ±¤´ë»Àµ¹±â¿Í ¿¬°áÇÏ¸ç ±¤´ë»ÀȰÀ» ¸¸µç´Ù. ¸öü´Â 4¸éÀÌ ÀÖÀ¸¸ç ¾Æ·¡ÂÊ ³»¸éÀº À§ÅλÀÀÇ ±¤´ë»Àµ¹±â¿Í ºÀÇÕÇÑ´Ù. ¹Ù±ùÂʸ鿡´Â ±¤´ë»À¾ó±¼±¸¸ÛÀÌ °³±¸µÈ´Ù. À§ÂÊ ³»¸éÀº ´«È®¸éÀÌ¸ç ±¤´ë»À´«È®±¸¸ÛÀÌ °³±¸µÈ´Ù. ÈĸéÀº ¿·¸Ó¸®¸éÀÌ¸ç ±¤´ë»À ¿·¸Ó¸®±¸¸ÛÀÌ °³±¸µÈ´Ù. À̵é 3±¸¸ÛÀº ¸öü¸¦ °üÅëÇÏ´Â ±¤´ë»À°ü¿¡ ÀÇÇØ ¼·Î ¿¬¶ôµÇ¸ç ±¤´ë»À½Å°æÀÌ Áö³ª°£´Ù. |
||
| HCF | [fetal] head-to-cervix force; heparin cofactor; hereditary capillary fragility; highest common facto... |
|---|---|
| MCF | macrophage chemotactic factor; median cleft face; medium corpuscular fragility; microcomplement fixa... |
| OF | occipitofrontal; open field [test]; optical fundus; orbitofrontal; osmotic fragility; osteitis fibro... |
| VFS | vascular fragility syndrome |
| ABC | absolute basophil count; absolute bone conduction; acalculous biliary colic; acid balance control; a... |
| BPTB | Bone-patellar tendon-bone |
|---|---|
| AHO | Albright hereditary osteodystrophy |
| CHED | Congenital Hereditary Endothelial Dystrophy |
| HANE | Hereditary Angio Neurotic Edema |
| HAE | Hereditary Angio-Edema |
| capillary fragility | The lack of resistance, or susceptibility, of capillaries to damage or disruption under conditions of increased stress. (12 Dec 1998) |
|---|---|
| capillary fragility test | A tourniquet test used to determine presence of vitamin C deficiency or thrombocytopenia; a circle 2.5 cm in diameter, the upper edge of which is 4 cm below the crease of the elbow, is drawn on the inner aspect of the forearm, pressure midway between the systolic and diastolic blood pressure is applied above the elbow for 15 minutes, and a count of petechiae within the circle is made: 10, normal; 10 to 20, marginal zone; over 20, abnormal. See: Rumpel-Leede test. Synonym: capillary resistance test, vitamin C test. (05 Mar 2000) |
| osmotic fragility | The susceptibility, or lack of resistance, of erythrocytes to haemolysis when exposed to increasingly hypotonic saline solutions. (12 Dec 1998) |
| fragility | Brittleness; liability to break, burst, or disintegrate. Synonym: fragilitas. Origin: L. Fragilitas (05 Mar 2000) |
| fragility of the blood | The susceptibility, or lack of resistance, of erythrocytes to haemolysis when exposed to increasingly hypotonic saline solutions. (12 Dec 1998) |
| fragility test | A test that measures the resistance of erythrocytes to haemolysis in hypotonic saline solutions; erythrocytes to be tested are added to varying concentrations of saline (usually ranging from 0.85 to 0.10% sodium chloride with 0.05% increments), and beginning and complete haemolysis are measured; normal erythrocytes show initial haemolysis at concentrations of 0.45 to 0.39% and complete haemolysis at 0.33 to 0.30%; in hereditary spherocytosis the fragility of the erythrocytes is markedly increased, whereas in thalassaemia, sickle cell anaemia, and obstructive jaundice the fragility of the erythrocytes is usually reduced. Synonym: erythrocyte fragility test. (05 Mar 2000) |
| bone within a bone | <radiology> STOP heavy metal, S: sickle cell disease, T: Thorotrast, O: osteopetrosis, P: Paget's disease, heavy metals, hypervitaminosis D (12 Dec 1998) |
| Albright's hereditary osteodystrophy | An inherited form of hyperparathyroidism associated with ectopic calcification and ossification and skeletal defects, notably the small fourth metacarpals, but intelligence is normal. There are dominant, recessive and X-linked forms. See: pseudohypoparathyroidism. Synonym: Albright's syndrome. (05 Mar 2000) |
| angioedema, hereditary | A genetic form of angioedema. (Angioedema is also referred to as Quinke's disease.) Persons with it are born lacking an inhibitor protein (called C1 esterase inhibitor) that normally prevents activation of a cascade of proteins leading to the swelling of angioedema. Patients can develop recurrent attacks of swollen tissues, pain in the abdomen, and swelling of the voice box (larynx) which can compromise breathing. The diagnosis is suspected with a history of recurrent angioedema. It is confirmed by finding abnormally low levels of C1 esterase inhibitor in the blood. Treatment options include antihistamines and male steroids (androgens) that can also prevent the recurrent attacks. Also called hereditary angioneurotic oedema. (12 Dec 1998) |
| angioneurotic oedema, hereditary | A genetic form of angioedema. (Angioedema is also referred to as Quinke's disease.) Persons with it are born lacking an inhibitor protein (called C1 esterase inhibitor) that normally prevents activation of a cascade of proteins leading to the swelling of angioedema. Patients can develop recurrent attacks of swollen tissues, pain in the abdomen, and swelling of the voice box (larynx) which can compromise breathing. The diagnosis is suspected with a history of recurrent angioedema. It is confirmed by finding abnormally low levels of C1 esterase inhibitor in the blood. Treatment options include antihistamines and male steroids (androgens) that can also prevent the recurrent attacks. Also called hereditary angioedema. (12 Dec 1998) |
| canine hereditary blindness | An autosomal dominant condition seen in dogs of the collie and several other breeds. (05 Mar 2000) |
| colourectal neoplasms, hereditary nonpolyposis | A syndrome characterised by autosomal dominant inheritance, a low mean age (41 years) for occurrence of colon cancer, and a marked increase in the proportion of tumours in the proximal colon. (12 Dec 1998) |
| corneal dystrophies, hereditary | Bilateral hereditary disorders of the cornea, usually autosomal dominant, which may be present at birth but more frequently develop during adolescence and progress slowly throughout life. Central macular dystrophy is transmitted as an autosomal recessive defect. (12 Dec 1998) |
| hereditary | <genetics> Transferred via genes from parent to child. (16 Dec 1997) |
| hereditary amyloidosis | <neurology> A disorder in which various peripheral nerves are infiltrated with amyloid and their functions disturbed, an abnormal prealbumin is also formed and is present in the blood; characteristically, it begins during mid-life and is found largely in persons of Portuguese descent. Other rare clinical types occur. Inheritance: autosomal dominant. Synonym: familial amyloidosis, hereditary amyloidosis. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|